Mouse models of human cancer unit
  Main Page   Staff
  infrastructure   Publication        
  Mouse models of human cancer unit


Staff Directory


Vinay Tergaonkar obtained his Ph.D. (2001), from National Center for Biological Sciences, Bangalore. During his graduate studies he was awarded an international cancer society (UICC) fellowship for collaborative research at Tufts University, Boston, USA. He has been a fellow (2001-2004) and a special fellow (2004-present) of the Leukemia and Lymphoma Society of America and conducted his postdoctoral studies at the Salk Institute for Biological Studies, La Jolla, California. He joined IMCB in late 2005 as Principal Investigator (Assistant professor) and became a Senior Principal Investigator (Associate professor) in 2010 and Research Director (Professor) in 2015.

He holds adjunct appointments at 1) Department of Biochemistry (NUS) 2) Cancer Science Institute, 3) Singapore Eye Research Institute and 4) National Cancer Centre, Singapore. He has been invited to speak at various international venues and meetings such as the Barossa and Hunter valley meetings in Australia, Genes and Cancer meeting in UK, The Argentine Pharmacological society meeting in Buenos Aires, Aichi and Japanese Cancer Society meetings in Japan and the Keystone Symposia. He serves on Editorial Boards of 1) Biochemical Journal (Portland Press) 2) Critical Reviews in Oncology/Hematology (Elsevier Press), 3) BMC Research Notes (Biomed Central) 4) Telomeres and Telomerase and 5) Molecular and Cellular Biology (American Society for Microbiology, Jan 2016). He has received international recognition for his work including the British council development award (2014) and the Premier's fellowship from Government of South Australia (2015)



Manikandan LAKSHMANAN – Co-Head

Manikandan Lakshmanan obtained his PhD (2004) in Pharmacology from Jadavpur University, Kolkata. He has more than eight years of Drug Discovery experience in various pharmaceutical companies such as Ranbaxy Laboratories Limited (now Daiichi Sankyo) and Syngene International Limited. He has been awarded 5 patents with two of the molecules currently in Phase I/II clinical trials. Prior to joining IMCB he was working as Senior Scientist with Forma (S) Therapeutics Pvt Ltd., where he was a part of a team that out-licensed a tumor metabolism program.

Team Members

filler filler filler

postdoctoral fellow


Chen Li CHEW          



filler filler filler


filler filler filler

Research Officers


Anandhkumar RAJU          


Surendar ARUMUGAM  


Erica Shiyi WONG          



filler filler filler